Industrial biotechnology

Renewable routes to acrylic acid, the C3 monomer behind superabsorbent polymers, paints, coatings and adhesives, across two distinct value chains: bioethanol-derived bio-based acrylate esters already commercial at Arkema (Carling, France, bio-based ethyl acrylate at 40% bio carbon content since October 2024) and BASF (Ludwigshafen, portfolio switched to bio-based ethyl acrylate in August 2024), and direct fermentative acrylic-acid routes via 3-hydroxypropionic acid (Cargill's Issatchenkia orientalis SD108 platform) or direct yeast fermentation (Genomatica's Saccharomyces cerevisiae host at ~30 mg/L laboratory titre) still at pilot or research scale — no Chinese commercial originator confirmed as of 2026.

Industrial binders from soy protein, kraft lignin and mussel-inspired catechol polymers that replace formaldehyde resins in wood panels, packaging and underwater repair.

Bio-based plasticizers replace regulated petroleum-derived phthalates (DEHP, DBP, DINP — under EU REACH SVHC and US EPA scrutiny for endocrine-disrupting effects) with renewable alternatives: epoxidized soybean oil (ESO/ESBO, the leading non-phthalate at ~8.4% of China's plasticizer consumption), isosorbide diesters (from starch/sorbitol), citrate esters (ATBC, food-contact), cardanol-based (from cashew nutshell liquid), and mass-balance bio-attributed resins (ISCC PLUS). Arkema secured ISCC PLUS mass balance certification for its Pasir Gudang Malaysia resins plant (Feb 2025) and brought a $20M Rilsan® Clear transparent polyamide unit online in Singapore (Q1 2026, 45-62% bio-based carbon from castor oil); Lanxess launched a sustainable Mesamoll® version with bio-mass raw materials and presented Vulkanox 4060 (6PPD alternative) at Tire Technology Expo 2026 (Hannover, March). ESO/ESBO dominates on volume (Cargill US, VVF India, Shandong Longkou China), approved for food-contact PVC under FDA 21 CFR 178 and EU REACH.

Renewable hydroxyl-functional building blocks from vegetable oils, lignin and cashew nutshell liquid that replace petrochemical polyols and isocyanates in flexible foams, coatings, TPU and elastomers — closing the carbon loop of a >$90 bn polyurethane market.

How a bio-based claim is made provable — ISCC PLUS chain-of-custody certification over mass-balanced production, radiocarbon measurement of biogenic carbon under ASTM D6866, and the digital product passport regime the EU adopted in July 2026 to carry such claims through the supply chain.

Replacing chlorinated-solvent and petroleum-based degreasers with lipase enzymes and living microbial cultures that continuously digest oil and grease inside the wash fluid itself — from a benchtop parts washer that never needs its solvent replaced to industrial biodegradable degreasing lines for metal, textile and food-processing equipment.

Environmentally safe adhesives and coatings derived from lignin, soy proteins, starch, and plant oils, designed to replace formaldehyde resins and petrochemical epoxies in construction, packaging, and food preservation.

Replacing energy-intensive metal and chemical catalysts in petrochemical synthesis with engineered enzymes, immobilized flow reactors and cell-free systems — high selectivity, mild conditions, reusable catalysts across platform and fine chemicals.

The certification machinery that decides whether a material may be called compostable — EN 13432 and ASTM D6400 conformity, the Seedling scheme whose 2026 revision tightens biodegradability evidence for minor constituents, home-compost certification at 180 days, and the laboratory battery of biodegradation, disintegration, ecotoxicity and heavy-metal testing beneath the labels.

Flexible and rigid polyurethane foams built from castor- and soy-oil bio-polyols with embedded biodegradation enzymes, replacing petrochemical polyols and HFC blowing agents in mattresses, automotive seating and furniture cushioning.

Bio-based dyes and pigments produced via microbial fermentation and synthetic biology.

Engineered luciferases and fluorescent proteins derived from jellyfish, deep-sea shrimp and other marine organisms, redesigned via directed evolution and computational protein design into ultra-bright, photostable research tools for drug screening, cell imaging and protein-protein interaction detection.

Advanced inline and online bioprocess sensors utilizing optics, capacitance, and spectrometry for real-time monitoring of biomass, metabolites, and dissolved gases in industrial fermentation.

Bio-derived solvents — ethyl lactate from fermented lactic acid (Corbion's Biviture brand, Galactic's Galactic bio-solvents line, Vertec Biosolvents' corn-based MEK-replacements now under Shrieve Chemical ownership) and bioethanol-derived ethyl acetate — replacing MEK, toluene and xylene in paints, coatings, industrial degreasing and pharma processing, alongside BASF's biomass-balanced BMBcert intermediates that attribute renewable carbon into existing solvent families via mass-balance accounting — a mature commercial niche with no dedicated Chinese or Indian originator confirmed as of 2026.

Microbial surface-active glycolipids (rhamnolipids, sophorolipids, MELs) produced by aerobic fermentation of plant oils and sugars — biodegradable, low-toxicity replacements for petrochemical surfactants in detergents, personal care, agchem and enhanced oil recovery.

Enzymatic conversion of acrylonitrile to acrylamide via immobilized Rhodococcus rhodochrous cells, replacing copper-catalyzed synthesis for water-treatment, mining and papermaking flocculants.

Renewable routes to 1,3-butadiene, the C4 monomer behind synthetic rubber and ABS plastics, via two competing chemistries: catalytic bioethanol-to-butadiene conversion (Axens/Michelin/IFPEN's BioButterfly, ETB Global in the Netherlands) and methane gas fermentation (BioVerde Tech and Unibio in a 2026 partnership) — both still at demonstration or early-pilot scale, with no confirmed Chinese or Indian commercial originator as of 2026.

Producing CBD, THC and rare cannabinoids (CBG, CBDV, THCV) as platform molecules via engineered yeast fermentation and chemo-enzymatic synthesis, bypassing plant cultivation.

Capsaicin — the pungent capsaicinoid of Capsicum peppers — is at the intersection of plant-cell biotechnology (Debut's cultivation-free fermentation), precision-fermentation flavour modulation (DSM-Firmenich, Givaudan) and a centuries-old capsicum-oleoresin extraction base anchored in India by Plant Lipids; fermentation-route biosynthesis remains emerging while extraction still dominates global supply.

Producing the world's most ubiquitous petrochemical building block from renewable biomass and captured carbon.

Microbial precision fermentation of hyaluronic acid to a defined molecular weight and pharmacopoeia-grade purity — a B2B biopolymer API for ophthalmic viscoelastics, dermal fillers, orthopedic viscosupplementation and premium cosmetics, under FDA, EMA and NMPA oversight.

Natural rubber and latex produced outside the Hevea plantation belt — from the desert shrub guayule, from Russian dandelion, and from fermentation-derived monomers — driven by Hevea supply volatility, the EU deforestation regulation and the hypoallergenic character of guayule latex, with the guayule segment alone valued at 187.4 million USD in 2026.

L-menthol supply in 2026 is dominated by conventional routes under active capacity expansion — BASF's triple-digit-million-euro world-scale menthol/linalool plant at Ludwigshafen (Apr 2026) and Symrise's 50-year synthetic-menthol franchise in the EU, alongside NMPA-licensed API extraction (Huangshan Tianmu Mint Pharmaceutical, license renewed to 2030) and food-grade dispersion formulation (Jiangsu Caiwei, 0.001-0.5% precision dosing) in China — while dedicated fermentation-route biosynthesis remains at the academic/patent stage with no company-specific commercial originator confirmed.

Bio-based platform chemicals — succinic acid, itaconic acid, FDCA, and 1,4-BDO — produced via precision fermentation from C5/C6 sugars, replacing fossil feedstocks for biopolymers, plastics, and specialty chemicals; $5B market in 2025, growing >15% CAGR to 2030.

The confirmed 2026 commercial market for non-animal musk is dominated by established macrocyclic ketone/lactone brands — Givaudan's Velvione (a 16-membered macrocyclic musk ketone) and DSM-Firmenich's Exaltolide — plus IFF's newly launched Orionide Oliffac clean-musk line (unveiled at SIMPPAR 2026) and, in China, Beijing Lianxin Pharmaceutical's state-designated Class-1 artificial-musk substitute for traditional-medicine use (founded 1999, National S&T Progress Award), while the engineered-yeast fermentation route described in early research (omega-oxidation, lipase-catalyzed macrocyclization) remains at the patent-application stage with no confirmed commercial fermentation-musk originator.

Yeast- and algae-fermented triglyceride oils that reproduce the fatty-acid profile of palm oil, offering deforestation-free B2B fats for food, cosmetics and biofuels.

High-value molecules — flavors, fragrances, food ingredients and bio-based monomers — produced by precision fermentation, biocatalysis and lignocellulose biorefinery from renewable carbon instead of petrochemicals or extraction.

Theobromine (3,7-dimethylxanthine) — cocoa's signature xanthine alkaloid — is sourced today from cocoa-processing byproducts (Cargill) and methylxanthine API manufacturing (Bajaj Healthcare, CSPC Innovation Pharma), while precision-fermentation and deforestation-free molecular synthesis (DSM-Firmenich, Fermtech) emerge under EU Deforestation Regulation pressure; this article covers the pure molecule, distinct from cocoa-free chocolate alternatives.

Microbial and fungal biofabrication replacing petrochemical and animal-derived textile inputs — from mycelium leather and collagen hides to DNA-encoded dyeing and enzymatic finishing.

Cell-free protein synthesis (CFPS) bypasses the living cell: ribosomes and translation factors in a reaction tube deliver the target protein in hours, not weeks, with toxic and non-canonical amino acids incorporated.

Fermentation-derived hyaluronic acid, recombinant collagen, bio-squalane and ingestible actives replacing animal- and petrochemical-derived cosmetic ingredients across China, the US and the EU.

Downstream purification converts crude bioreactor harvests into clinical-grade drug substance — chromatography (Protein A, IEX, HIC), tangential-flow filtration, and viral clearance together account for >50% of biomanufacturing CAPEX. The global DSP market exceeds $5B and grows at >8% CAGR driven by mAb and cell-gene therapy demand.

Thermostable xylanase and laccase-mediator enzymes dosed directly into hot unbleached kraft pulp at paper mills, cutting chlorine dioxide consumption 20-30% and toxic AOX effluent while pushing the industry toward Totally Chlorine Free standards.

Keratinases, lipases and transglutaminase replace sulfide unhairing and chromium tanning in leather processing, cutting wastewater toxicity and chemical-oxygen-demand load while producing chrome-free, Leather Working Group-certifiable hides for premium fashion and automotive interiors.

Cell-free directed synthesis of high-molecular-weight polymers utilizing purified recombinant enzymes ex vivo, eliminating metabolic constraints to produce ultra-pure biomaterials for regenerative medicine and high-end cosmetics.

Purpose-built anaerobic bioreactors — tall bubble-column loop vessels, hollow-fiber cell-retention skids, and multi-stage gas cleanup trains — that let acetogenic bacteria convert steel-mill and refinery waste gas (CO, CO2, H2) into ethanol at commercial scale, one plant already running at 210,000 tonnes/year of biofuel-grade output.

Advanced green extraction technologies including supercritical CO2, deep eutectic solvents, and ultrasound intensification for zero-residue bioactive recovery.

Industrial enzymes and biocatalysis replace chemical processes with protein-catalyzed reactions — cutting energy by 40–70%, reagent costs, and waste streams across food, feed, pharma, textiles, and biofuels. The global market exceeds $7B with >6% CAGR through 2030.

Synthetic gene circuits that force engineered organisms to depend on external chemical signals for survival, self-destructing or losing viability once released into the environment — the biocontainment standard now required before any regulator clears a synthetic-biology product for open-system field trials.

Industrial-scale fermentation of L-lactic acid, the upstream monomer feedstock for polylactic acid (PLA) bioplastics — fermentation scale-up, PLA-integrated value chains, and feedstock diversification: NatureWorks in the US, Corbion and Futerro in Europe, and Henan Jindan Lactic Acid in China.

Depolymerising the lignin fraction of woody biomass into renewable aromatic platform chemicals — vanillin, phenolics, BTX and lignosulfonate dispersants — replacing petrochemical aromatics.

Rational design and optimization of microbial metabolic pathways to produce high-value chemicals, advanced materials, and alternative proteins at industrial scale.

Cosmetic bio-actives — prebiotics, postbiotics and bacterial lysates — and biome-friendly bases that nourish the skin's commensal flora (not live drugs): a fast-growing clean-beauty segment built on 16S rRNA profiling and selective preservation.

Small (100–300 μm) suspended particles whose surface lets anchorage-dependent cells grow inside ordinary stirred-tank and single-use bioreactors — the consumable that turns adherent biology (vaccines, cell therapy, cultivated meat) into a scalable, GMP industrial process.

Automated mini- and micro-bioreactors (1-250 mL) running 24-48 cultures in parallel that map a bioprocess Design Space in days rather than months — the high-throughput on-ramp to cell-line, strain and upstream-process development, led by the German ambr, BioLector and DASbox platforms.

The frontier of building life de novo — stripping genomes down to a minimal viable chassis (top-down) and assembling artificial cells from non-living parts (bottom-up) to make predictable, biocontained cell factories.

Closed engineered systems — flat-panel airlift, tubular and single-use bag reactors — that cultivate microalgae under controlled light and CO2 dosing to produce astaxanthin, omega-3 oils, pigments and, increasingly, carbon-capture feedstock for SAF.

Precision-fermentation-derived collagen and gelatin — produced in engineered yeast or via plant molecular farming rather than animal hide and bone extraction — for food, dietary-supplement, wound-care and tissue-engineering applications, eliminating prion-contamination risk and batch variability.

Precision-fermentation collagen engineered specifically for skincare and injectable aesthetic medicine — matching the human collagen sequence, free of prion and allergenicity risk, and small enough to penetrate skin's epidermal barrier — powering China's dominant recombinant-collagen skincare industry and premium Western dermal-filler and cosmetic-ingredient lines.

High-performance protein fibers spun from microbially fermented spidroins — matching the tensile strength of steel and the toughness of Kevlar at a fraction of the weight, without farming spiders.

Industrial automation software orchestrating complex bioreactor operations and enforcing regulatory compliance through electronic batch records.

Pre-sterilized, fully integrated polymer fluid paths and containment bags that eliminate cross-contamination, bypass intensive cleaning validation, and drastically compress biomanufacturing facility footprints.

Gamma-irradiated single-use bag bioreactors in the 50-2000 L stirred-tank class — Sartorius Biostat STR, Cytiva Xcellerex XDR, Thermo Fisher HyPerforma, Merck Mobius — that replaced stainless steel for clinical and commercial mAb, vaccine and cell-and-gene-therapy manufacturing, cutting facility build-out from years to weeks and underpinning the CDMO economy.

Solid-state fermentation (SSF) bioreactors cultivate filamentous fungi, yeasts and bacteria on moist solid substrates — wheat bran, soybeans, rice, bagasse — at 40–70% moisture without free liquid, producing industrial enzymes (Aspergillus phytase, xylanase), organic acids, koji for shoyu/miso/sake, and biocontrol conidia (Beauveria, Trichoderma) at 3–5× lower cost than submerged fermentation, engineered around tray, rotating-drum and forced-aeration packed-bed hardware that solve SSF's defining challenges of heat removal, moisture control and oxygen transfer in a low-water matrix.

Contract organisations that engineer the microbe or enzyme itself — directed evolution, computational protein design and genome editing of production strains — delivering measured process gains such as a substrate loading raised from 5 to 67 g/L and enzyme load cut from 100 to 3 weight percent, rather than selling a molecule.

The engineering of biology — designing DNA, cells and genetic circuits on computers, building them in biofoundries and scaling them into chemicals, materials and ingredients through the Design-Build-Test-Learn cycle.

Fermentation-derived terpenes and terpenoids — farnesene, limonene, valencene, squalane — replacing petrochemical and plant-extracted equivalents in cosmetics, flavors, fragrances and fuel additives as microbial mevalonate-pathway engineering scales.

Orthogonal biological systems built on xeno-nucleic acids, unnatural base pairs and genomically recoded organisms that incorporate noncanonical amino acids into proteins — enabling site-specific drug conjugation and a genetic firewall against horizontal gene transfer with wild species.